Partner with us

We鈥檙e听committed to building sustainable relationships across the scientific and business communities听that help us combine transformative advances in the understanding of human disease with the science of therapeutics, all with the goal of听advancing听human health.

Female scientist speaks with business partner

We鈥檙e听committed to building sustainable relationships across the scientific and business communities听that help us combine transformative advances in the understanding of human disease with the science of therapeutics, all with the goal of听advancing听human health.

Collaboration defines our culture

We know that collaborating with the world鈥檚 experts is a cornerstone to solving some of science鈥檚 most difficult problems.听Collaboration听is one of our core values听at Vertex 鈥 it defines our culture.

two female business partners in a meeting


Externally, our collaborations with companies, academia, research organizations and nonprofit organizations help drive scientific innovation and the development of new medicines.

two female business partners in a meeting


Internally, it creates an environment that encourages the open exchange of ideas and provides the freedom for our talented employees to explore new scientific concepts. Our Vertex Opportunities for Intrapreneurship & Corporate Evolution (VOICE) program is a great example.听Check it out here.

Partnerships enhance scientific innovation

To support听our听mission, we seek external partnerships that promote scientific innovation, and we鈥檙e focused on creating relationships that are grounded in deep biological knowledge of a disease and target.听We believe that innovation should not be limited to opportunities based听solely on specific stages of development or听on听particular treatment听modalities.

Scientific equipment inside fume hood
Our current priorities include:
  • Supporting听Vertex鈥檚听cystic fibrosis strategy of bringing innovative medicines to patients听by complementing our existing research efforts and clinical assets with听additional tools听and/or technologies.听

  • Diversifying our portfolio with potentially transformative medicines in diseases听where there is听a high unmet need.听

  • Leveraging cutting-edge technology platforms to accelerate the discovery of new disease targets, compounds, delivery mechanisms and potential treatment modalities.听

  • Maximizing the potential of听Vertex听assets by using strategic collaborations and licensing opportunities to enable speedy and thorough development.听

Vertex is a trusted partner

Female businesswoman speaking in meeting

We value developing strategic relationships听that are mutually beneficial. Our approach is to create successful partnerships with well-articulated principles and value propositions. Our portfolio of alliances consists of a variety of collaboration models to meet听the听different needs of our partners.听

Vertex works to maximize the value of our partnerships for both organizations, seeking to make decisions that align our common goals and, most importantly, bring benefits to patients as quickly as possible. We work collaboratively to make informed and strategic decisions to rapidly progress our partnered programs.

Areas of interest

We're actively exploring all approaches that may change the treatment of a serious disease where no adequate treatment currently exists. We are seeking technologies that will enable exploration of new diseases or disease targets.

Please also contact us if you'd like to explore a potential partnership related to any of the following:

White background

Our global network of innovation

Targets and Human Cell Models
Genomics plc logo

Genomics plc

announcement

Innovation in Small Molecule Therapeutics
X-Chem Pharmaceuticals logo

X-Chem

announcement

Kymera logo

Kymera

announcement

Ribometrix logo

Ribometrix

announcement

Skyhawk Therapeutics logo

Skyhawk Therapeutics

announcement

Stablix logo

Stablix

听announcement

Cell and Genetic Therapies
CRISPR Therapeutics logo

CRISPR Therapeutics

听announcement

听announcement

Moderna logo

Moderna

announcement

announcement

Affinia Therapeutics logo

Affinia Therapeutics

announcement

Arbor logo

Arbor Biotechnologies

announcement

Mammoth Biosciences logo

Mammoth Biosciences

announcement

Obsidian Therapeutics logo

Obsidian Therapeutics

announcement

Verve Therapeutics logo

Verve Therapeutics

announcement

Entrada Therapeutics logo

Entrada Therapeutics

announcement

Tevard Biosciences logo

Tevard Biosciences

announcement

ImmunoGen logo

ImmunoGen

announcement

Lonza logo

Lonza

announcement